The UK is struggling to keep up with the growing number of patients at local GP surgeries.
The chief executive of the UK National Health Service (NHS) Simon Stevens has called on the government to increase its funding to address rising demand and creeping costs.
The UK is trying to find a smooth course through its exit from the European Union but there are warning signs that the safety of patients in hospitals might be compromised by a combination of existing and new challenges.
A recent study has found that only 43 percent of cancer drugs recently approved in Europe allowed patients to live longer, or improved their quality of life.
The past 15 years have witnessed an explosion in the drugs market for multiple sclerosis (MS), enabling the first disease modifying therapies in the neurodegenerative disease market to become a reality.
The FDA has been on the right track when taking forward promising pipeline drugs for expedited new drug application (NDA) review.
If you’re sick the treatment you get is not specifically matched to you; it’s the same as for everyone else with that condition.
Samsung is a name readily associated with smartphones and wide-screen TVs, but the company has been broadening its horizons in recent years.
The varying result of medical studies results can make catchy headlines.
Cases of antibiotic-resistant super gonorrhea are rising rapidly according to the World Health Organization (WHO).
Alzheimer’s disease is the most common form of dementia, affecting 46.8m people worldwide.
Cancer therapy was historically dominated by chemotherapy and hormonal therapies, but now a new drug class is poised to seize a market share of more than $35bn.
Over the next few years Sanofi will go from being an also-ran in the dermatology arena to being a major player, thanks to the performance of a groundbreaking new drug.
In the lead up to the UK’s departure from the EU, efforts are being made to ensure the stability of the healthcare and pharmaceutical industries.
So far in 2017 there have been two major measles outbreaks in developed countries: one in Europe and the other in Minnesota in the US.
Universal basic income is becoming an increasingly debated topic around the world today, with Finland, the Canadian province of Ontario, and even Kenya beginning trials to test its feasibility.
As divorce talks between the UK and the European Union get underway, the country could soon be deprived of some of its best scientific minds.
A breakthrough in migraine treatment is expected to create a $5bn dollar industry and improve the lives of millions of sufferers worldwide.
In the US 56.4m people are believed to suffer from acne.
One of the many issues that needs to be negotiated in the wake of British prime minister Theresa May’s triggering of Article 50 is the location of the European Medicines Agency (EMA).
Depression is the leading cause of disability worldwide, affecting over 300m people – but less than half of them are getting effective treatment.
Drug development is a lengthy, complicated and costly process, with a high rate of attrition.
Shooting cancer cells with lasers or programming particles to explode within deep-lying tumours may sound like the stuff of science fiction but using nanotechnology to fight cancer is already a reality.
As the world’s first human head transplant rapidly approaches, it’s time to face the implications this could have for the future of surgery and pharma therapy.
After many decades of prohibition doctors in the US now prescribe medical cannabis for a range of conditions, from HIV and Aids, to nausea and vomiting in cancer patients, pain and epilepsy.
Global pharmaceutical stock indices rose by up to 12 percent after Donald Trump’s US election victory in November.
Drug-resistant so-called superbugs kill at least 700,000 worldwide each year and deaths are expected to rise to 10m per year by 2050, according to economist Jim O’Neill.